why ADO is a multi multi bagger, page-6567

You recall correctly—SIIO are the only ones (MB excluded) who truly get it.

They understand the massive value opportunity that life sciences are sitting on.

At this stage, I wouldn’t be surprised to see them taking a slice of the company or picking up the shortfall of shares not allocated at 2.5 cents.

Alternatively, they could opt for a funding arrangement with future buy-in clauses and/or profit-sharing structures.

With $7 million, they could secure up to 37% of the company and provide a full year of runway until the end of 2026.

and/or they after visiting to make a large order for a vaccine?

Time is ticking—only 16 days left in the month of May, and there’s bound to be movement at the station.